Article
Cell therapy could benefit from BCG: how anti-tumour BCG-primed NK cells selectively proliferate over other lymphocytes and efficiently kill cancer cells
2023-09-25
Abstract excerpt
<title>Abstract</title> <p>Natural killer (NK) cell-based immunotherapies are safe, promising treatments for patients with cancer. Nevertheless, the short-lived nature of NK cells, the heterogeneity of NK populations and the need to infuse large number of cells for efficient tumour elimination represent important challenges for the development of NK cell-based therapies. Therefore, improved approaches to produce...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bd9a7b6b-7b33-52bd-9872-bb7b4df1e03c
- DOI
- 10.21203/rs.3.rs-3356129/v1
